FDA considering accelerated approval of new Alzheimer’s drug

The FDA is considering accelerated approval of a new drug shown to attack amyloid plaque in the human brain, a contributing cause of cognitive dysfunction in dementia and Alzheimer’s disease.  The FDA is expected to reach a decision by Friday, January 6.

Allina EMS crew meets twin babies it helped deliver inside ambulance

Nearly three months after delivering twin babies in an ambulance, two local EMS workers were formally introduced to the little girls that they helped bring into the world. For the babies’ parents, the meeting was also an opportunity to give thanks.

Thanksgiving is no holiday for health care workers

Holiday or not, the work at Twin Cities hospitals never stops. And Thanksgiving looked a lot like any other Thursday for health care professionals. And while many are spending the holiday at work, they plan to celebrate with their loved ones with leftovers soon.